Skip to main content
Clinical Trials/TCTR20160418002
TCTR20160418002
Active, not recruiting
Phase 2

Effect of breathing with a positive expiratory pressure device during exercise at submaximal intensity on physiological changes in patients with COPD

associated medical science KK0 sites21 target enrollmentApril 18, 2016
ConditionsCOPD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
COPD
Sponsor
associated medical science KK
Enrollment
21
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 18, 2016
End Date
May 31, 2016
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
associated medical science KK

Eligibility Criteria

Inclusion Criteria

  • 1\. FEV1/FVC \< 70%
  • 2\. Moderate stage; 50% 3\. Severe stage; 30% 4\. Age 40 to 80 year old
  • 5\. Has a 10 pack\-year smoking history
  • 6\. Good communication

Exclusion Criteria

  • 1\. Cardiovascular system contraindications for exercise and exercise testing
  • 2\. Long\-term oxygen therapy or pulse oxygen saturation \< 90% at rest
  • 3\. Clinical unstable and exacerbations, defined by increase in chronic inhaled therapy, within the last four weeks
  • 4\. Musculoskeletal pain or weakness that limit independent exercise
  • 5\. Cardiovascular disease e.g. coronary disease, anemia, heart failure, and uncontrolled hypertension
  • 6\. Neurological impairment e.g. poor balance and co\-ordination, abnormal movement
  • 7\. Patients who have to use medicine that reduces heart rate (Beta 2\-blocker, Diltiazem, Isoptin, etc.)

Outcomes

Primary Outcomes

Not specified

Similar Trials